BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Julphar
Baxter
Dow
Moodys
Accenture
McKesson
Medtronic
US Army
Johnson and Johnson

Generated: January 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 204054

« Back to Dashboard

NDA 204054 describes MECAMYLAMINE HYDROCHLORIDE, which is a drug marketed by Nexgen Pharma and is included in one NDA. It is available from three suppliers. Additional details are available on the MECAMYLAMINE HYDROCHLORIDE profile page.

The generic ingredient in MECAMYLAMINE HYDROCHLORIDE is mecamylamine hydrochloride. There are three drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the mecamylamine hydrochloride profile page.
Summary for 204054
Tradename:MECAMYLAMINE HYDROCHLORIDE
Applicant:Nexgen Pharma
Ingredient:mecamylamine hydrochloride
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 204054
Medical Subject Heading (MeSH) Categories for 204054
Suppliers and Packaging for NDA: 204054
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
MECAMYLAMINE HYDROCHLORIDE mecamylamine hydrochloride TABLET;ORAL 204054 ANDA Nexgen Pharma, Inc. 0722-7183 0722-7183-01 100 TABLET in 1 BOTTLE (0722-7183-01)
MECAMYLAMINE HYDROCHLORIDE mecamylamine hydrochloride TABLET;ORAL 204054 ANDA Manchester Pharmaceuticals 45043-558 45043-558-40 100 TABLET in 1 BOTTLE (45043-558-40)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength2.5MG
Approval Date:Mar 19, 2013TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKesson
Baxter
Teva
Chinese Patent Office
Citi
Mallinckrodt
Cipla
AstraZeneca
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot